Back to All Events

Vaccines and Related Biological Products Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

The US FDA on February 15, 2022 has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss a request to amend the Emergency Use Authorization (EUA) of the Pfizer-BioNTech’s COVID-19 mRNA vaccine for administration to children 6 months through 4 years of age.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-february-15-2022-meeting-announcement
Earlier Event: February 10
Oncologic Drugs Advisory Committee
Later Event: February 15
Joint Meeting of the Committee and the Drug Safety and Risk Management Advisory Committee